Eurofins Scientific's earnings have been declining at an average annual rate of -16.9%, while the Life Sciences industry saw earnings declining at 3.7% annually. Revenues have been growing at an average rate of 2.3% per year. Eurofins Scientific's return on equity is 11.4%, and it has net margins of 6.4%.
Key information
-16.86%
Earnings growth rate
-15.41%
EPS growth rate
Life Sciences Industry Growth
21.51%
Revenue growth rate
2.28%
Return on equity
11.35%
Net Margin
6.36%
Last Earnings Update
30 Jun 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Eurofins Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:ERFS.F Revenue, expenses and earnings (EUR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Jun 26
7,386
470
114
0
31 Mar 26
7,341
443
115
0
31 Dec 25
7,296
416
115
0
30 Sep 25
7,220
399
69
0
30 Jun 25
7,144
381
70
0
31 Mar 25
7,048
369
95
0
31 Dec 24
6,951
356
119
0
30 Sep 24
6,837
341
121
0
30 Jun 24
6,724
326
122
0
31 Mar 24
6,619
291
123
0
31 Dec 23
6,515
257
125
0
30 Sep 23
6,512
335
126
0
30 Jun 23
6,510
414
128
0
31 Mar 23
6,611
497
128
0
31 Dec 22
6,712
581
128
0
30 Sep 22
6,785
612
123
0
30 Jun 22
6,857
643
117
0
31 Mar 22
6,787
696
116
0
31 Dec 21
6,718
749
115
0
30 Sep 21
6,553
786
117
0
30 Jun 21
6,388
824
118
0
31 Mar 21
5,913
665
119
0
31 Dec 20
5,439
505
119
0
30 Sep 20
5,079
347
120
0
30 Jun 20
4,719
190
120
0
31 Mar 20
4,641
168
119
0
31 Dec 19
4,563
146
117
0
30 Sep 19
4,384
144
111
0
30 Jun 19
4,205
143
106
0
31 Mar 19
3,993
159
98
0
31 Dec 18
3,781
175
90
0
30 Sep 18
3,549
182
82
0
30 Jun 18
3,318
190
75
0
31 Mar 18
3,145
185
62
0
31 Dec 17
2,971
179
48
0
30 Sep 17
2,848
166
42
0
30 Jun 17
2,725
152
35
0
31 Mar 17
2,631
145
37
0
31 Dec 16
2,537
138
38
0
30 Sep 16
2,427
104
35
0
30 Jun 16
2,317
69
32
0
31 Mar 16
2,133
63
31
0
31 Dec 15
1,950
56
30
0
30 Sep 15
1,779
71
27
0
Quality Earnings: ERFS.F has high quality earnings.
Growing Profit Margin: ERFS.F's current net profit margins (6.4%) are higher than last year (5.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ERFS.F's earnings have declined by 16.9% per year over the past 5 years.
Accelerating Growth: ERFS.F's earnings growth over the past year (23.3%) exceeds its 5-year average (-16.9% per year).
Earnings vs Industry: ERFS.F earnings growth over the past year (23.3%) exceeded the Life Sciences industry 12.6%.
Return on Equity
High ROE: ERFS.F's Return on Equity (11.4%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/28 16:54
End of Day Share Price
2026/07/28 00:00
Earnings
2026/06/30
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Eurofins Scientific SE is covered by 31 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.